ECSP14013263A - Inhibidores de la enzima activadora de nedd8 - Google Patents
Inhibidores de la enzima activadora de nedd8Info
- Publication number
- ECSP14013263A ECSP14013263A ECSP14013263A ECSP14013263A EC SP14013263 A ECSP14013263 A EC SP14013263A EC SP14013263 A ECSP14013263 A EC SP14013263A EC SP14013263 A ECSP14013263 A EC SP14013263A
- Authority
- EC
- Ecuador
- Prior art keywords
- inhibitors
- activating enzyme
- nedd8 activating
- chemical entities
- nedd8
- Prior art date
Links
- 102000038427 NEDD8-activating enzyme E1 Human genes 0.000 title abstract 3
- 108091007790 NEDD8-activating enzyme E1 Proteins 0.000 title abstract 3
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 150000005829 chemical entities Chemical class 0.000 abstract 2
- -1 sulfamate compound Chemical class 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161526830P | 2011-08-24 | 2011-08-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP14013263A true ECSP14013263A (es) | 2014-04-30 |
Family
ID=47747080
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP14013263 ECSP14013263A (es) | 2011-08-24 | 2014-03-21 | Inhibidores de la enzima activadora de nedd8 |
Country Status (29)
| Country | Link |
|---|---|
| US (3) | US8809356B2 (enExample) |
| EP (2) | EP3323414A1 (enExample) |
| JP (1) | JP6038150B2 (enExample) |
| KR (1) | KR20140054288A (enExample) |
| CN (1) | CN103889988B (enExample) |
| AR (1) | AR087672A1 (enExample) |
| AU (1) | AU2012298813B2 (enExample) |
| BR (1) | BR112014004239A2 (enExample) |
| CA (1) | CA2846231C (enExample) |
| CL (1) | CL2014000441A1 (enExample) |
| CO (1) | CO6900148A2 (enExample) |
| CR (1) | CR20140128A (enExample) |
| DO (1) | DOP2014000037A (enExample) |
| EA (1) | EA031067B1 (enExample) |
| EC (1) | ECSP14013263A (enExample) |
| GE (1) | GEP201606522B (enExample) |
| HK (1) | HK1199252A1 (enExample) |
| IL (1) | IL231069B (enExample) |
| MA (1) | MA35439B1 (enExample) |
| MX (1) | MX2014002015A (enExample) |
| MY (1) | MY166889A (enExample) |
| PE (1) | PE20141146A1 (enExample) |
| PH (1) | PH12014500419A1 (enExample) |
| SG (2) | SG10201601023UA (enExample) |
| TN (1) | TN2014000080A1 (enExample) |
| TW (1) | TWI577667B (enExample) |
| UA (1) | UA114894C2 (enExample) |
| UY (1) | UY34292A (enExample) |
| WO (1) | WO2013028832A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8008307B2 (en) | 2006-08-08 | 2011-08-30 | Millennium Pharmaceuticals, Inc. | Heteroaryl compounds useful as inhibitors of E1 activating enzymes |
| MY166889A (en) * | 2011-08-24 | 2018-07-24 | Millennium Pharm Inc | Inhibitors of nedd8-activating enzyme |
| UA116534C2 (uk) | 2012-02-17 | 2018-04-10 | Мілленніум Фармасьютікалз, Інк. | Піразолопіримідинілові інгібітори убіквітинактивуючого ферменту |
| US9593121B2 (en) | 2012-08-03 | 2017-03-14 | Millennium Pharmaceuticals, Inc. | Indole substituted pyrrolopyrimidinyl inhibitors of Uba6 |
| EP2764866A1 (en) | 2013-02-07 | 2014-08-13 | IP Gesellschaft für Management mbH | Inhibitors of nedd8-activating enzyme |
| EA032577B1 (ru) * | 2013-07-02 | 2019-06-28 | Милленниум Фармасьютикалз, Инк. | Гетероарильные соединения, пригодные в качестве ингибиторов sumo-активирующего фермента |
| CN103948590A (zh) * | 2014-05-22 | 2014-07-30 | 中国药科大学 | Nedd8激活酶抑制剂及其医药用途 |
| RS59474B1 (sr) | 2014-07-01 | 2019-12-31 | Millennium Pharm Inc | Heteroarilna jedinjenja koja su korisna kao inhibitori sumo-aktivirajućeg enzima |
| WO2017183927A1 (ko) * | 2016-04-20 | 2017-10-26 | 한국화학연구원 | 신규한 헤테로고리 화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 암의 예방 또는 치료용 약학적 조성물 |
| WO2018213258A1 (en) * | 2017-05-15 | 2018-11-22 | Millennium Pharmaceuticals, Inc. | Treatment of merlin-deficient tumors using nae inhibitors |
| PL3792260T3 (pl) | 2018-05-08 | 2024-12-02 | Nippon Shinyaku Co., Ltd. | Związki azabenzimidazolowe i środki farmaceutyczne |
| WO2023025668A1 (en) | 2021-08-25 | 2023-03-02 | Asociación Centro De Investigación Cooperativa En Biociencias-Cic Biogune | Methods for the generation of stem cell memory t cells for adoptive t cell therapy |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5194446A (en) | 1989-06-12 | 1993-03-16 | A. H. Robins Company, Incorporated | Compounds having one or more aminosulfaonyloxy radicals useful as pharmaceuticals |
| WO1997005132A1 (en) | 1995-07-28 | 1997-02-13 | Cubist Pharmaceuticals, Inc. | Aminoacyl adenylate mimics as novel antimicrobial and antiparasitic agents |
| AU2003291024A1 (en) | 2002-11-13 | 2004-06-03 | Rigel Pharmaceuticals, Inc. | Rhodanine derivatives and pharmaceutical compositions containing them |
| US20050130974A1 (en) | 2003-10-17 | 2005-06-16 | Rigel Pharmaceuticals, Inc. | Benzothiazole compositions and their use as ubiquitin ligase inhibitors |
| WO2006002284A1 (en) | 2004-06-22 | 2006-01-05 | Rigel Pharmaceuticals, Inc. | Ubiquitin ligase inhibitors |
| EP1848718B1 (en) | 2005-02-04 | 2012-08-01 | Millennium Pharmaceuticals, Inc. | Inhibitors of e1 activating enzymes |
| CN106008512B (zh) * | 2006-02-02 | 2019-03-12 | 千禧药品公司 | E1活化酶抑制剂 |
| US8008307B2 (en) | 2006-08-08 | 2011-08-30 | Millennium Pharmaceuticals, Inc. | Heteroaryl compounds useful as inhibitors of E1 activating enzymes |
| NZ574513A (en) * | 2006-08-08 | 2012-02-24 | Millennium Pharm Inc | Heteroaryl compounds useful as inhibitors of e1 activating enzymes |
| CN102421780A (zh) * | 2009-05-14 | 2012-04-18 | 米伦纽姆医药公司 | 氨基磺酸((1s，2s，4r)-4-{4-[(1s)-2，3-二氢-1h-茚-1-基氨基]-7h-吡咯并[2，3-d]嘧啶-7-基}-2-羟基环戊基)甲酯盐酸盐 |
| MY166889A (en) * | 2011-08-24 | 2018-07-24 | Millennium Pharm Inc | Inhibitors of nedd8-activating enzyme |
| KR101987861B1 (ko) * | 2011-11-03 | 2019-06-11 | 밀레니엄 파머슈티컬스 인코퍼레이티드 | Nedd-8 활성화 효소 억제제 및 저메틸화제의 투여 |
-
2012
- 2012-08-23 MY MYPI2014000482A patent/MY166889A/en unknown
- 2012-08-23 UA UAA201402893A patent/UA114894C2/uk unknown
- 2012-08-23 GE GEAP201213424A patent/GEP201606522B/en unknown
- 2012-08-23 MX MX2014002015A patent/MX2014002015A/es unknown
- 2012-08-23 PH PH1/2014/500419A patent/PH12014500419A1/en unknown
- 2012-08-23 AU AU2012298813A patent/AU2012298813B2/en not_active Ceased
- 2012-08-23 SG SG10201601023UA patent/SG10201601023UA/en unknown
- 2012-08-23 HK HK14112794.7A patent/HK1199252A1/xx unknown
- 2012-08-23 BR BR112014004239A patent/BR112014004239A2/pt not_active Application Discontinuation
- 2012-08-23 KR KR1020147007200A patent/KR20140054288A/ko not_active Abandoned
- 2012-08-23 US US13/592,389 patent/US8809356B2/en active Active
- 2012-08-23 PE PE2014000250A patent/PE20141146A1/es active IP Right Grant
- 2012-08-23 JP JP2014527287A patent/JP6038150B2/ja not_active Expired - Fee Related
- 2012-08-23 SG SG11201400102WA patent/SG11201400102WA/en unknown
- 2012-08-23 EP EP17193006.8A patent/EP3323414A1/en not_active Withdrawn
- 2012-08-23 CN CN201280052013.2A patent/CN103889988B/zh not_active Expired - Fee Related
- 2012-08-23 EA EA201400249A patent/EA031067B1/ru not_active IP Right Cessation
- 2012-08-23 WO PCT/US2012/052007 patent/WO2013028832A2/en not_active Ceased
- 2012-08-23 EP EP12825411.7A patent/EP2748168A4/en not_active Withdrawn
- 2012-08-23 CA CA2846231A patent/CA2846231C/en not_active Expired - Fee Related
- 2012-08-24 TW TW101130884A patent/TWI577667B/zh not_active IP Right Cessation
- 2012-08-24 UY UY0001034292A patent/UY34292A/es not_active Application Discontinuation
- 2012-08-24 AR ARP120103134A patent/AR087672A1/es unknown
-
2014
- 2014-02-20 IL IL231069A patent/IL231069B/en active IP Right Grant
- 2014-02-21 TN TNP2014000080A patent/TN2014000080A1/en unknown
- 2014-02-24 DO DO2014000037A patent/DOP2014000037A/es unknown
- 2014-02-24 CL CL2014000441A patent/CL2014000441A1/es unknown
- 2014-03-12 CO CO14052377A patent/CO6900148A2/es unknown
- 2014-03-13 MA MA36826A patent/MA35439B1/fr unknown
- 2014-03-17 CR CR20140128A patent/CR20140128A/es unknown
- 2014-03-21 EC ECSP14013263 patent/ECSP14013263A/es unknown
- 2014-07-08 US US14/326,051 patent/US9850214B2/en active Active
-
2017
- 2017-11-09 US US15/808,491 patent/US20180290983A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP14013263A (es) | Inhibidores de la enzima activadora de nedd8 | |
| MX2019006299A (es) | Compuestos de pirazola sustituida y metodos para usarlos para el tratamiento de enfermedades hiperproliferativas. | |
| GT201400131A (es) | Derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina | |
| GT201500051A (es) | Inhibidores de glucosilceramida sintasa | |
| GT201300215A (es) | Inhibidores de glucosilceramida sintasa | |
| CR20140397A (es) | Compuestos de oxazolidin-2-ona y usos de los mismos como inhibidores de la pi3ks | |
| CR20150045A (es) | Inhibidores de hepatitis c | |
| MX387487B (es) | Compuestos polifluorados que actúan como inhibidores de la tirosina cinasa de bruton. | |
| TR201816379T4 (tr) | DNA-PK inhibitörleri. | |
| BR112015000399A2 (pt) | derivados de pirazolil pirimidina | |
| MX2016004030A (es) | Inhibidores sustituidos de nicotinamida de btk y su preparacion y uso en el tratamiento del cancer, inflamacion y enfermedad autoinmune. | |
| CR20130550A (es) | Ciclopropilaminas como inhibidores de desmetilasa 1 específica de lisina | |
| CU24265B1 (es) | Compuestos derivados de benzamida para inhibir la actividad de abl1, abl2 y bcr-abl1, útiles en el tratamiento del cáncer | |
| MX2014015287A (es) | Derivado del ester del acido heteroarilcarboxilico. | |
| MX355428B (es) | Formas cristalinas del acido [ (4-hidroxi-1-metil-7-fenoxi-isoquin olin-3-carbonil) -amino] -acetico inhibidor de prolil hidroxilasa. | |
| ECSP13012770A (es) | Formas cristalinas de 5-cloro-n2-(2-isopropoxi-5-metil-4-piperidin-4-il-fenil)-n4-[2-(propan-2-sulfonil)-fenil]-pirimidin-2,4-diamina | |
| PE20160113A1 (es) | Procesos de fabricacion y formas cristalinas de un inhibidor de mdm2 | |
| BR112015006874A2 (pt) | ligantes de rig-i inovadores e métodos para produzir os mesmos | |
| EA201400976A1 (ru) | Бензодиоксаны в комбинации с другими активными средствами для ингибирования продуцирования лейкотриена | |
| EA201301130A1 (ru) | Имидазопиридазины в качестве ингибиторов акт киназы | |
| CR20140553A (es) | Compuestos de fenoxietil piperidina | |
| PH12015500363A1 (en) | Prodrugs of amino quinazoline kinase inhibitor | |
| TN2015000120A1 (en) | Oxazolidin-2-one-pyrimidine derivatives | |
| DOP2013000304A (es) | Moduladores alostéricos positivos del receptor de acetilcolina nicotínico | |
| CR20130583A (es) | Moduladores alostéricos positivos del receptor de acetilcolina nicotínico |